CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,187 Cr | ₹1,937 Cr | ₹1,694 Cr | ₹1,467 Cr | ₹1,269 Cr |
What is the latest Revenue of CAPLIN POINT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,187 Cr |
| Mar2025 | ₹1,937 Cr |
| Mar2024 | ₹1,694 Cr |
| Mar2023 | ₹1,467 Cr |
| Mar2022 | ₹1,269 Cr |
How is Revenue of CAPLIN POINT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,187 Cr | 12.89 | |
| Mar2025 | ₹1,937 Cr | 14.37 | |
| Mar2024 | ₹1,694 Cr | 15.50 | |
| Mar2023 | ₹1,467 Cr | 15.54 | |
| Mar2022 | ₹1,269 Cr | - | |
Compare Revenue of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹20,936.1 Cr | -2.1% | 10.3% | 28.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -2.1% |
10.3% |
28.4% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses